rs8031627

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005902.4(SMAD3):​c.*1245G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 230,062 control chromosomes in the GnomAD database, including 7,013 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3813 hom., cov: 32)
Exomes 𝑓: 0.26 ( 3200 hom. )

Consequence

SMAD3
NM_005902.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.539

Publications

21 publications found
Variant links:
Genes affected
SMAD3 (HGNC:6769): (SMAD family member 3) The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. This protein forms a complex with other SMAD proteins and binds DNA, functioning both as a transcription factor and tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, May 2022]
SMAD3 Gene-Disease associations (from GenCC):
  • aneurysm-osteoarthritis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 15-67191781-G-A is Benign according to our data. Variant chr15-67191781-G-A is described in ClinVar as Benign. ClinVar VariationId is 316896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMAD3NM_005902.4 linkc.*1245G>A 3_prime_UTR_variant Exon 9 of 9 ENST00000327367.9 NP_005893.1 P84022-1A0A024R5Z3Q9P0T0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMAD3ENST00000327367.9 linkc.*1245G>A 3_prime_UTR_variant Exon 9 of 9 1 NM_005902.4 ENSP00000332973.4 P84022-1

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30611
AN:
152062
Hom.:
3812
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0737
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.461
Gnomad SAS
AF:
0.287
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.287
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.237
GnomAD4 exome
AF:
0.265
AC:
20621
AN:
77882
Hom.:
3200
Cov.:
0
AF XY:
0.264
AC XY:
9479
AN XY:
35878
show subpopulations
African (AFR)
AF:
0.0788
AC:
294
AN:
3730
American (AMR)
AF:
0.312
AC:
748
AN:
2396
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
1648
AN:
4934
East Asian (EAS)
AF:
0.474
AC:
5231
AN:
11034
South Asian (SAS)
AF:
0.302
AC:
205
AN:
678
European-Finnish (FIN)
AF:
0.116
AC:
13
AN:
112
Middle Eastern (MID)
AF:
0.296
AC:
142
AN:
480
European-Non Finnish (NFE)
AF:
0.226
AC:
10829
AN:
48022
Other (OTH)
AF:
0.233
AC:
1511
AN:
6496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
699
1398
2097
2796
3495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.201
AC:
30631
AN:
152180
Hom.:
3813
Cov.:
32
AF XY:
0.206
AC XY:
15339
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0737
AC:
3061
AN:
41540
American (AMR)
AF:
0.316
AC:
4836
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.331
AC:
1150
AN:
3470
East Asian (EAS)
AF:
0.462
AC:
2393
AN:
5178
South Asian (SAS)
AF:
0.286
AC:
1378
AN:
4820
European-Finnish (FIN)
AF:
0.181
AC:
1918
AN:
10580
Middle Eastern (MID)
AF:
0.288
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
0.222
AC:
15117
AN:
67988
Other (OTH)
AF:
0.238
AC:
503
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1200
2400
3601
4801
6001
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.217
Hom.:
5462
Bravo
AF:
0.207
Asia WGS
AF:
0.335
AC:
1164
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aneurysm-osteoarthritis syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.74
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8031627; hg19: chr15-67484119; COSMIC: COSV107381610; COSMIC: COSV107381610; API